Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Logo

Bb Biotech Ag decreased its stake in Regeneron Pharmaceuticals Inc. (REGN) by 25.93% based on its latest 2018Q3 regulatory filing with the SEC. Bb Biotech Ag sold 70,000 shares as the company’s stock declined 4.42% with the market. The institutional investor held 200,000 shares of the health care company at the end of 2018Q3, valued at $80.81 million, down from 270,000 at the end of the previous reported quarter. Bb Biotech Ag who had been investing in Regeneron Pharmaceuticals Inc. for a number of months, seems to be less bullish one the $44.18 billion market cap company. The stock increased 0.14% or $0.57 during the last trading session, reaching $408.63. About 757,999 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has risen 1.07% since January 12, 2018 and is uptrending. It has outperformed by 1.07% the S&P500. Some Historical REGN News: 11/05/2018 – Bayer: Eylea Treats Visual Impairment From Macular Degeneration; 03/05/2018 – Regeneron Pharma 1Q Rev $1.51B; 11/05/2018 – Bayer’s Eylea Gets Second Approval for Use in China; 10/03/2018 – REGENERON, SANOFI SAY THEY WILL MEET ICER’S RECOMMENDED PRICE; 19/03/2018 – EYLEA® (AFLIBERCEPT) INJECTION DEMONSTRATES POSITIVE TOPLINE RESULTS IN PHASE 3 NON-PROLIFERATIVE DIABETIC RETINOPATHY TRIAL; 03/05/2018 – REGENERON PHARMACEUTICALS INC – QTRLY PRALUENT GLOBAL SALES $60 MLN VS $36 MLN; 28/03/2018 – Regeneron CEO ‘optimistic’ will strike deals to lower $14,000 per-year cholesterol drug; 19/03/2018 – #3 With Novartis and Roche gunning to carve up Eylea franchise, Regeneron has another PhIII success story to tell $NVS $RHHBY $REGN; 21/03/2018 – REGENERON & ALNYLAM PHARMACEUTICALS REPORT PACT TO DISCOVER NEW; 19/03/2018 – REGENERON PHARMACEUTICALS – EXPECT U.S. REGULATORY SUBMISSION FOR DIABETIC RETINOPATHY LATER THIS YEAR

Cliftonlarsonallen Wealth Advisors Llc decreased its stake in Nextera Energy Inc (NEE) by 77.71% based on its latest 2018Q3 regulatory filing with the SEC. Cliftonlarsonallen Wealth Advisors Llc sold 37,259 shares as the company’s stock rose 6.15% while stock markets declined. The institutional investor held 10,686 shares of the public utilities company at the end of 2018Q3, valued at $1.79M, down from 47,945 at the end of the previous reported quarter. Cliftonlarsonallen Wealth Advisors Llc who had been investing in Nextera Energy Inc for a number of months, seems to be less bullish one the $83.98 billion market cap company. The stock increased 0.18% or $0.32 during the last trading session, reaching $175.71. About 2.22M shares traded. NextEra Energy, Inc. (NYSE:NEE) has risen 15.44% since January 12, 2018 and is uptrending. It has outperformed by 15.44% the S&P500. Some Historical NEE News: 21/05/2018 – NextEra Energy reaches definitive agreements to acquire Gulf Power, Florida City Gas and additional assets from Southern; 29/05/2018 – Entergy, NextEra Energy Resources celebrate commissioning of Arkansas’ largest universal solar energy project; 02/04/2018 – NEXTERA ENERGY PARTNERS – AN AFFILIATE OF CO TO CONTINUE TO OPERATE ALL FACILITIES INCLUDED IN DEAL UNDER A 10-YEAR SERVICES AGREEMENT WITH CPPIB; 24/04/2018 – NEXTERA ENERGY 1Q ADJ EPS $1.94, EST. $1.82; 26/04/2018 – NEXTERA ENERGY INC NEE.N : JP MORGAN RAISES TARGET PRICE TO $171 FROM $170; 24/04/2018 – NextEra Energy 1Q EPS $9.32; 02/04/2018 – NEXTERA ENERGY PARTNERS LP – DEAL INCLUDES ASSUMPTION BY PURCHASER OF APPROXIMATELY $689 MLN IN EXISTING DEBT; 30/03/2018 – NextEra Energy and JinkoSolar announce deal for millions of solar panels; JinkoSolar to begin manufacturing solar panels in Florida; 21/05/2018 – NextEra Energy to Finance $5.1B Purchase Price Through Issuance of New Debt; 21/05/2018 – NextEra Energy May Be Required to Pay Southern Co Termination Fee of $100M or $200M if Asset Sale Terminated — Filing

Cliftonlarsonallen Wealth Advisors Llc, which manages about $2.03 billion and $1.07 billion US Long portfolio, upped its stake in Ishares Tr (AGG) by 20,855 shares to 777,455 shares, valued at $82.04 million in 2018Q3, according to the filing. It also increased its holding in Ishares Tr (HYG) by 5,586 shares in the quarter, for a total of 166,024 shares, and has risen its stake in Ishares Tr (IXC).

More recent NextEra Energy, Inc. (NYSE:NEE) news were published by: Finance.Yahoo.com which released: “Should Income Investors Buy NextEra Energy Inc (NYSE:NEE) Before Its Ex-Dividend? – Yahoo Finance” on May 31, 2018. Also Seekingalpha.com published the news titled: “Nextera: A Strong Business For Your Portfolio – Seeking Alpha” on December 04, 2018. Prnewswire.com‘s news article titled: “NextEra Energy completes acquisition of Gulf Power from Southern Company – PRNewswire” with publication date: January 01, 2019 was also an interesting one.

Since August 22, 2018, it had 0 insider buys, and 11 selling transactions for $25.21 million activity. $3.07 million worth of NextEra Energy, Inc. (NYSE:NEE) was sold by ROBO JAMES L. $272,364 worth of NextEra Energy, Inc. (NYSE:NEE) was sold by SCHUPP RUDY E. On Wednesday, October 10 the insider CUTLER PAUL I sold $1.93M. $2.92 million worth of NextEra Energy, Inc. (NYSE:NEE) was sold by Silagy Eric E on Wednesday, August 22. Kelliher Joseph T sold $1.39 million worth of NextEra Energy, Inc. (NYSE:NEE) on Monday, September 17. Sieving Charles E sold $3.55M worth of stock or 19,731 shares.

Investors sentiment increased to 1.11 in Q3 2018. Its up 0.05, from 1.06 in 2018Q2. It is positive, as 28 investors sold NEE shares while 390 reduced holdings. 91 funds opened positions while 373 raised stakes. 344.15 million shares or 0.13% less from 344.59 million shares in 2018Q2 were reported. Sg Americas Lc holds 0.03% or 26,745 shares in its portfolio. Monetary Management Grp Incorporated reported 3,000 shares or 0.19% of all its holdings. Moreover, Lomas Cap Management Ltd has 5.29% invested in NextEra Energy, Inc. (NYSE:NEE). Janney Montgomery Scott Limited Liability has 191,449 shares. Personal Advisors stated it has 156,194 shares. Farmers & Merchants Invs holds 0.05% or 4,753 shares in its portfolio. West Oak Capital Ltd holds 16,408 shares. Strategy Asset Managers Ltd Llc reported 0% of its portfolio in NextEra Energy, Inc. (NYSE:NEE). Moreover, Smith Salley & Assoc has 0.05% invested in NextEra Energy, Inc. (NYSE:NEE) for 1,900 shares. Etrade Cap Mgmt Limited Liability Company reported 27,415 shares. Georgia-based Thomasville Commercial Bank has invested 0.2% in NextEra Energy, Inc. (NYSE:NEE). Barometer Cap has invested 1.22% in NextEra Energy, Inc. (NYSE:NEE). Kings Point Mngmt invested in 0.1% or 3,043 shares. Lifeplan Financial Grp Incorporated owns 3,616 shares or 0.33% of their US portfolio. Sequoia Advsr Limited Liability holds 3,220 shares or 0.05% of its portfolio.

Among 18 analysts covering Nextera Energy Inc. (NYSE:NEE), 15 have Buy rating, 0 Sell and 3 Hold. Therefore 83% are positive. Nextera Energy Inc. had 58 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of NextEra Energy, Inc. (NYSE:NEE) has “Overweight” rating given on Tuesday, September 11 by Morgan Stanley. The stock of NextEra Energy, Inc. (NYSE:NEE) earned “Overweight” rating by KeyBanc Capital Markets on Thursday, July 19. M Partners maintained the stock with “Buy” rating in Tuesday, August 11 report. As per Friday, March 18, the company rating was maintained by Barclays Capital. The firm earned “Overweight” rating on Wednesday, April 18 by KeyBanc Capital Markets. The company was maintained on Friday, September 21 by Morgan Stanley. Argus Research maintained NextEra Energy, Inc. (NYSE:NEE) rating on Friday, August 7. Argus Research has “Buy” rating and $118 target. On Wednesday, December 13 the stock rating was maintained by Morgan Stanley with “Overweight”. The rating was maintained by Deutsche Bank with “Buy” on Monday, October 5. The rating was maintained by Wells Fargo with “Outperform” on Monday, September 17.

Analysts await NextEra Energy, Inc. (NYSE:NEE) to report earnings on January, 25. They expect $1.55 earnings per share, up 24.00% or $0.30 from last year’s $1.25 per share. NEE’s profit will be $740.82 million for 28.34 P/E if the $1.55 EPS becomes a reality. After $2.18 actual earnings per share reported by NextEra Energy, Inc. for the previous quarter, Wall Street now forecasts -28.90% negative EPS growth.

Bb Biotech Ag, which manages about $3.78 billion US Long portfolio, upped its stake in Argenx Se by 285,690 shares to 734,739 shares, valued at $55.72 million in 2018Q3, according to the filing. It also increased its holding in Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) by 230,000 shares in the quarter, for a total of 1.37M shares, and has risen its stake in Myovant Sciences Ltd..

Analysts await Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to report earnings on February, 14. They expect $5.10 earnings per share, up 14.35% or $0.64 from last year’s $4.46 per share. REGN’s profit will be $551.44 million for 20.03 P/E if the $5.10 EPS becomes a reality. After $5.10 actual earnings per share reported by Regeneron Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Investors sentiment decreased to 1.14 in Q3 2018. Its down 0.05, from 1.19 in 2018Q2. It dived, as 39 investors sold REGN shares while 173 reduced holdings. 89 funds opened positions while 153 raised stakes. 70.41 million shares or 0.23% more from 70.25 million shares in 2018Q2 were reported. Focused Wealth Mngmt Inc owns 2,118 shares. Howe & Rusling owns 25 shares or 0% of their US portfolio. California State Teachers Retirement Sys invested in 127,454 shares or 0.1% of the stock. First Allied Advisory Inc holds 1,454 shares or 0.04% of its portfolio. Johnson Group Inc Inc holds 50 shares or 0% of its portfolio. Lpl Financial Limited Co invested 0.02% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Founders Cap Limited Liability Co has invested 0.09% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Cutter & Com Brokerage stated it has 0.62% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). 2,500 were reported by Quantitative Investment Mgmt Limited Liability Corporation. Moreover, Two Sigma Securities has 0.01% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Amundi Pioneer Asset Mgmt stated it has 0.08% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Capital Investors stated it has 1.74 million shares. Alabama-based Andra Ap has invested 0.13% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Scotia Cap reported 757 shares. Bluemountain Capital Management Ltd Liability Corporation invested in 0.01% or 1,919 shares.

More notable recent Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) news were published by: Nasdaq.com which released: “Nasdaq 100 Movers: COST, REGN – Nasdaq” on December 14, 2018, also Seekingalpha.com with their article: “Regeneron Pharmaceuticals beats by $0.73, beats on revenue – Seeking Alpha” published on November 06, 2018, Nasdaq.com published: “Noteworthy Friday Option Activity: ARNC, REGN, CRM – Nasdaq” on January 04, 2019. More interesting news about Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) were released by: Seekingalpha.com and their article: “Regeneron: The Catalysts – Seeking Alpha” published on July 05, 2018 as well as Nasdaq.com‘s news article titled: “REGN Crosses Above Average Analyst Target – Nasdaq” with publication date: January 11, 2019.

Since August 22, 2018, it had 0 buys, and 7 sales for $46.41 million activity. 1,848 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares with value of $663,381 were sold by Fenimore Christopher R.. VAGELOS P ROY sold 6 shares worth $2,294. Another trade for 104,552 shares valued at $42.52M was sold by Sanofi. 2,709 shares were sold by GOLDSTEIN JOSEPH L, worth $1.09 million on Thursday, September 27.

Among 34 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 13 have Buy rating, 1 Sell and 20 Hold. Therefore 38% are positive. Regeneron Pharmaceuticals Inc. had 139 analyst reports since July 28, 2015 according to SRatingsIntel. As per Monday, September 4, the company rating was maintained by Jefferies. The firm has “Hold” rating by J.P. Morgan given on Monday, August 14. The firm earned “Sell” rating on Wednesday, May 23 by Barclays Capital. The company was upgraded on Tuesday, February 16 by Chardan Capital Markets. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has “Hold” rating given on Wednesday, February 21 by Canaccord Genuity. Robert W. Baird downgraded the shares of REGN in report on Friday, August 5 to “Neutral” rating. Leerink Swann maintained Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday, August 15 with “Buy” rating. The firm has “Buy” rating given on Tuesday, March 15 by Gabelli. On Monday, November 27 the stock rating was maintained by BMO Capital Markets with “Hold”. The firm has “Hold” rating given on Friday, February 9 by SunTrust.

NextEra Energy, Inc. (NYSE:NEE) Institutional Positions Chart




Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *